Clinical Trial Update: Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of SYNB1891 alone or with atezolizumab in adults with metastatic solid tumors or lymphoma; the study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• SYNB1891
• Tecentriq (atezolizumab)

Snippet

Sponsor: Synlogic | Conditions: Metastatic Solid Neoplasm, Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2024-05-03